CLASS II Device recall · Reported 25 Jan 2017 · FDA Enforcement Report

Optilite Freelite Lambda Free Kit Product recalled

The Binding Site Group is recalling Optilite Freelite Lambda Free Kit, distributed in 7 states. The recall was initiated on 5 Jul 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #405566, 405567
Quantity recalled809 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1043-2017
FDA event ID
76048
Recalling firm
The Binding Site Group, Birmingham
Classification
Class II
Status
Terminated
Recall initiated
5 Jul 2016
FDA classified
18 Jan 2017
Reported
25 Jan 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

5 Jul 2016Recall initiated by company
18 Jan 2017Classified by FDA+197 days
25 Jan 2017Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Batch numbers listed are reporting Lambda Free Light Chain results >114mg/L that are on average 33% lower than other Optilite Lambda Freelite batches. Therefore users moving to this batch will see results >114mg/L giving lower results and conversely when switching to the next batch results will be seen to shift upwards.

Product as listed by the FDA

Optilite Freelite Lambda Free Kit Product Code: LK018.OPT, LK018.OPT.A Protein testing kit.

Where it was distributed

U.S. distribution to the following; AR, PA, GA, NC, KY, VA, CA. Foreign distribution to the following; Uk, Germany, France, Italy, Spain, Czech Republic, Portugal, Belgium.

ArkansasCaliforniaGeorgiaKentuckyNorth CarolinaPennsylvaniaVirginia

Questions about this recall

Why was it recalled?

Batch numbers listed are reporting Lambda Free Light Chain results >114mg/L that are on average 33% lower than other Optilite Lambda Freelite batches. Therefore users moving to this batch will see results >114mg/L giving lower results and conversely when switching to the next batch results will be seen to shift upwards.

Which lots are affected?

Lot #405566, 405567

Where was it sold?

U.S. distribution to the following; AR, PA, GA, NC, KY, VA, CA. Foreign distribution to the following; Uk, Germany, France, Italy, Spain, Czech Republic, Portugal, Belgium.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from The Binding Site Group

All 29

Other Other Medical Devices recalls

All 13,950